Episode Details

Back to Episodes
Episode 105: A Phase 2 study of novel immune combinations (ICOS) in bladder cancer

Episode 105: A Phase 2 study of novel immune combinations (ICOS) in bladder cancer

Season 1 Episode 107 Published 5 years, 4 months ago
Description

Arjun Balar discusses this and his neoadjuvant chemo/immune/RT trial.

Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us